Trials / Completed
CompletedNCT03525080
Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors
Diagnostic Assessment Study, Single Site and Prospective, comparing18F-DOPA PET and Multiparametric RMI in Initial Exploration of Diffuse Glial Tumors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Center Eugene Marquis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
For patient having a brain tumor, RMI is the standard exam for tumor characterization and determines initial surgery. The aim of this study is to assess if PET could provide additional information that could have an impact on surgery (indication and planification)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET imagery | Every patients will have a PET imagery in addition to standard MRI |
Timeline
- Start date
- 2018-06-12
- Primary completion
- 2019-09-11
- Completion
- 2019-09-11
- First posted
- 2018-05-15
- Last updated
- 2020-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03525080. Inclusion in this directory is not an endorsement.